Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roopa Sethi

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Primary Care Companion for CNS Disorders|August 10, 2013
Are "bath salts" on your differential list? A case report of delirium and agitation after use of illicit bath saltsRoopa Sethi, Sachinder Vasudeva
Kansas Journal of Medicine|January 27, 2023
Illicit Non-Pharmaceutical Fentanyl and Its Analogs: A Short Review of LiteratureVivek Velagapudi, Roopa Sethi
Kansas Journal of Medicine|November 13, 2023
Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing FetusGrace Noonan, Roopa Sethi
The Primary Care Companion for CNS Disorders|March 8, 2013
Doxazosin for the treatment of nightmares: does it really work? A case reportRoopa Sethi, Sachinder Vasudeva
The Primary Care Companion for CNS Disorders|December 20, 2012
Hypothermia secondary to ziprasidone use in a man with schizophreniaRoopa Sethi, Bush Kavuru
The Primary Care Companion for CNS Disorders|August 4, 2016
Will Adding Methadone to Controlled Substance Monitoring Programs Help Psychiatrists Prevent Prescription Drug Overdoses?Dominic DiPrinzio, Roopa Sethi
The American Journal on Addictions|April 15, 2014
Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphineRoopa Sethi, Ismene Petrakis
The Primary Care Companion for CNS Disorders|November 3, 2023
The Appearance of Xylazine in the United States as a Fentanyl AdulterantCaitlin E Leconte, Roopa Sethi
The Primary Care Companion for CNS Disorders|November 17, 2023
The Role of Non-Pharmaceutical Fentanyl-Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary ReviewGrace E Hartmann, Roopa Sethi
The Primary Care Companion for CNS Disorders|February 22, 2020
Tapentadol: An Opioid of Abuse Acquired OnlineBrant S Ansley, Roopa Sethi
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Primary Care Companion for CNS Disorders|August 10, 2013
Are "bath salts" on your differential list? A case report of delirium and agitation after use of illicit bath saltsRoopa Sethi, Sachinder Vasudeva
Kansas Journal of Medicine|January 27, 2023
Illicit Non-Pharmaceutical Fentanyl and Its Analogs: A Short Review of LiteratureVivek Velagapudi, Roopa Sethi
Kansas Journal of Medicine|November 13, 2023
Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing FetusGrace Noonan, Roopa Sethi
The Primary Care Companion for CNS Disorders|March 8, 2013
Doxazosin for the treatment of nightmares: does it really work? A case reportRoopa Sethi, Sachinder Vasudeva
The Primary Care Companion for CNS Disorders|December 20, 2012
Hypothermia secondary to ziprasidone use in a man with schizophreniaRoopa Sethi, Bush Kavuru
The Primary Care Companion for CNS Disorders|August 4, 2016
Will Adding Methadone to Controlled Substance Monitoring Programs Help Psychiatrists Prevent Prescription Drug Overdoses?Dominic DiPrinzio, Roopa Sethi
The American Journal on Addictions|April 15, 2014
Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphineRoopa Sethi, Ismene Petrakis
The Primary Care Companion for CNS Disorders|November 3, 2023
The Appearance of Xylazine in the United States as a Fentanyl AdulterantCaitlin E Leconte, Roopa Sethi
The Primary Care Companion for CNS Disorders|November 17, 2023
The Role of Non-Pharmaceutical Fentanyl-Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary ReviewGrace E Hartmann, Roopa Sethi
The Primary Care Companion for CNS Disorders|February 22, 2020
Tapentadol: An Opioid of Abuse Acquired OnlineBrant S Ansley, Roopa Sethi
Pageof 5